Replies to post #6537 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I suggest you might combine section 6.5 licensing parameters within the Guidelines with the FDA-PEI commitment. Combine that with the hospital exemption statutes and reimbursement contingencies and one can easily (IMHO) make the case that FDA and fire-walled NWBO people could legally facilitate the exchange of information for "licensing" purposes. It's just my opinion though.